Pharmacists in Fishersville, VA Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Marielle Fares Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 Medical Center Dr, Fishersville, VA 22939 Phone: 540-332-4000 |
 Mr. Kyle J Becker, PHARM.D. Pharmacist - Oncology Medicare: Not Enrolled in Medicare Practice Location: 57 Beam Lane, Suite 300, Fishersville, VA 22939 Phone: 573-270-9105 |
Calvin Miller Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 78 Medical Center Drive, Pharmacy Department, Fishersville, VA 22939 Phone: 540-332-4000 |
Dr. Jordan Neil Markowitz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 Medical Center Dr, Fishersville, VA 22939 Phone: 540-332-4550 |
Dr. Andrew J Ventura, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 Medical Center Dr, Mis Department, Fishersville, VA 22939 Phone: 540-332-5709 |
Andrew Moyer, PHARM.D. Pharmacist - Critical Care Medicare: Not Enrolled in Medicare Practice Location: 78 Medical Center Drive, Department Of Pharmacy, Fishersville, VA 22939 Phone: 540-332-4556 |
Ms. Nancy Carol Heidel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 70 Medical Center Cir, Suite 101, Fishersville, VA 22939 Phone: 540-332-5946 Fax: 540-332-5948 |
News Archive
Scientists investigate sex-targeted drug delivery for traumatic brain injuries
New research has determined that the window of opportunity to provide possible treatments for patients suffering from traumatic brain injuries (TBIs) differs depending on whether the patient is male or female.
Researchers endeavor to create map of human brain's wiring using MEG technology
As a part of a $30 million dollar National Institutes of Health (NIH) initiative to map the human brain, Saint Louis University neurosurgeon Richard Bucholz, M.D. will image the brains of healthy adults with MEG technology, providing key information about brain function.
TapImmune announces results from HER2/neu interim study on breast cancer
TapImmune Inc. has announced that an interim safety analysis on the first five breast cancer patients treated with HER2/neu Class II antigens at Mayo Clinic, Rochester, MN., did not show any serious adverse events.
Capsules: Obamacare deadline for Jan. 1 coverage extended one week
Millions of consumers have been frustrated by their inability to sign up for coverage through healthcare.gov, the federal website for residents of 36 states, which went public Oct. 1. While the administration has said the site will work smoothly for most customers by Nov. 30, some advocates had been concerned that consumers still might not have enough time to sign up for coverage that would take effect Jan. 1.
› Verified 4 days ago
Occupational Therapists
Dentists
Counselors
Clinical Social Workers
Pharmacists